Nifty

:

17799.10

Sensex

:

60086.01

136.95 (0.78%)
536.11 (0.90%)

Login

Nifty
Sensex

:
:

17799.10
60086.01

136.95 (0.78%)
536.11 (0.90%)

Ind-Swift Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

40/99

BSE: 532305 | NSE: INDSWFTLAB

Watchlist

NSE BSE

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

380.22
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,311.25
N/A
0.85

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-0.89
6.38
10.04

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.59
7.85
6.40

PAT CAGR (%)

10 Years
5 Years
3 Years

-33.00
-
-53.36

P:E (Median)

8 Years
5 Years
3 Years

-
4.06
-

P:BV (Average)

8 Years
5 Years
3 Years

0.77
0.86
0.85

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.95
7.78
6.76

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 287.55 229.92 25.07% 271.52 242.05 12.18% 275.82 217.84 26.62% 240.30 221.20 8.63%
Expenses 230.69 175.35 31.56% 218.54 191.41 14.17% 240.74 176.66 36.27% 186.73 172.97 7.96%
EBITDA 56.85 54.57 4.18% 52.99 50.64 4.64% 35.08 41.18 -14.81% 53.57 48.23 11.07%
EBIDTM 19.77% 23.74% 19.51% 20.92% 12.72% 18.90% 22.29% 21.80%
Other Income 7.54 7.35 2.59% 7.39 6.37 16.01% 20.63 2.56 705.86% 7.99 5.79 38.00%
Interest 23.98 24.20 -0.91% 23.98 24.12 -0.58% 23.49 24.31 -3.37% 23.73 24.96 -4.93%
Depreciation 16.39 13.87 18.17% 16.26 14.06 15.65% 81.78 27.93 192.80% 21.26 19.84 7.16%
PBT 24.02 23.85 0.71% 20.14 18.83 6.96% -49.56 -8.50 - 14.87 9.22 61.28%
Tax 0.00 0.00 0 0.00 0.08 -100.00% 13.63 20.52 -33.58% 0.00 0.00 0
PAT 24.02 23.85 0.71% 20.14 18.75 7.41% -63.19 -29.02 - 14.87 9.22 61.28%
PATM 8.35% 10.37% 7.42% 7.75% -22.91% -13.32% 6.19% 4.17%
EPS 4.06 4.04 0.50% 3.41 3.17 7.57% -10.69 -4.91 - 2.52 1.56 61.54%

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 310.21 235.64 31.65% 280.17 249.80 12.16% 306.65 226.55 35.36% 246.64 226.26 9.01%
Expenses 251.46 179.59 40.02% 227.16 198.97 14.17% 269.95 184.90 46.00% 194.25 177.82 9.24%
EBITDA 58.75 56.06 4.80% 53.00 50.83 4.27% 36.69 41.64 -11.89% 52.39 48.44 8.15%
EBIDTM 18.94% 23.79% 18.92% 20.35% 11.97% 18.38% 21.24% 21.41%
Other Income 7.54 7.15 5.45% 7.39 6.37 16.01% 21.21 2.56 728.52% 8.41 8.84 -4.86%
Interest 23.98 24.19 -0.87% 23.98 24.12 -0.58% 23.49 24.31 -3.37% 23.73 25.91 -8.41%
Depreciation 16.41 13.91 17.97% 16.28 14.06 15.79% 81.81 27.93 192.91% 21.26 19.83 7.21%
PBT 25.91 25.10 3.23% 20.14 19.02 5.89% -47.40 -8.04 - 15.81 11.55 36.88%
Tax 0.56 0.63 -11.11% 0.22 0.21 4.76% 14.06 21.16 -33.55% -0.22 0.00 -
PAT 25.34 24.47 3.56% 19.92 18.80 5.96% -61.45 -29.19 - 16.03 11.55 38.79%
PATM 8.17% 10.38% 7.11% 7.53% -20.04% -12.89% 6.50% 5.10%
EPS 4.29 4.14 3.62% 3.36 3.18 5.66% -10.40 -4.94 - 2.71 1.95 38.97%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 1,075.19 988.09 856.58 751.84 724.43 728.33 674.90 638.74 645.74 940.66 1,082.70 Net Sales Growth 18.02% 15.35% 13.93% 3.78% -0.54% 7.92% 5.66% -1.08% -31.35% -13.12% Cost Of Goods Sold 551.86 487.31 424.99 378.85 379.33 372.09 377.00 344.31 398.54 737.30 865.14 Gross Profit 523.33 500.77 431.58 372.99 345.10 356.23 297.91 294.44 247.19 203.36 217.56 GP Margin 48.67% 50.68% 50.38% 49.61% 47.64% 48.91% 44.14% 46.10% 38.28% 21.62% 20.09% Total Expenditure 876.70 794.38 676.10 610.78 599.15 601.53 569.87 532.05 556.91 882.26 1,012.36 Power & Fuel Cost - 57.48 37.31 34.65 37.44 29.58 26.00 22.65 34.78 36.82 31.61 % Of Sales - 5.82% 4.36% 4.61% 5.17% 4.06% 3.85% 3.55% 5.39% 3.91% 2.92% Employee Cost - 102.18 95.47 93.58 88.94 85.22 67.53 60.74 48.20 42.59 38.75 % Of Sales - 10.34% 11.15% 12.45% 12.28% 11.70% 10.01% 9.51% 7.46% 4.53% 3.58% Manufacturing Exp. - 65.32 64.24 59.30 50.06 63.50 43.40 38.56 30.13 26.18 28.99 % Of Sales - 6.61% 7.50% 7.89% 6.91% 8.72% 6.43% 6.04% 4.67% 2.78% 2.68% General & Admin Exp. - 30.38 23.56 23.77 22.89 24.07 19.96 19.33 17.85 19.45 18.23 % Of Sales - 3.07% 2.75% 3.16% 3.16% 3.30% 2.96% 3.03% 2.76% 2.07% 1.68% Selling & Distn. Exp. - 37.78 28.74 20.24 20.41 27.00 28.12 27.89 27.31 13.09 23.47 % Of Sales - 3.82% 3.36% 2.69% 2.82% 3.71% 4.17% 4.37% 4.23% 1.39% 2.17% Miscellaneous Exp. - 13.93 1.77 0.40 0.07 0.06 7.86 18.57 0.09 6.82 23.47 % Of Sales - 1.41% 0.21% 0.05% 0.01% 0.01% 1.16% 2.91% 0.01% 0.73% 0.57% EBITDA 198.49 193.71 180.48 141.06 125.28 126.80 105.03 106.69 88.83 58.40 70.34 EBITDA Margin 18.46% 19.60% 21.07% 18.76% 17.29% 17.41% 15.56% 16.70% 13.76% 6.21% 6.50% Other Income 43.55 41.72 23.13 36.08 47.00 25.70 22.62 15.91 22.25 13.49 17.85 Interest 95.18 94.76 100.20 106.65 92.24 35.36 90.25 106.41 117.29 116.62 139.61 Depreciation 135.69 130.97 87.29 90.06 104.05 86.62 88.26 84.75 84.29 65.77 54.35 PBT 9.47 9.69 16.12 -19.56 -24.01 30.52 -50.85 -68.55 -90.49 -110.49 -105.77 Tax 13.63 13.70 20.52 1.23 20.35 10.96 -16.46 -24.28 -24.12 -20.46 -0.94 Tax Rate 143.93% 171.25% 127.30% -6.29% 34.53% 38.35% 29.29% 29.21% 16.83% 14.29% 0.78% PAT -4.16 -5.71 -4.40 -20.79 38.58 17.62 -39.73 -58.86 -119.16 -122.74 -118.97 PAT before Minority Interest -4.16 -5.71 -4.40 -20.79 38.58 17.62 -39.73 -58.86 -119.16 -122.74 -118.97 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -0.39% -0.58% -0.51% -2.77% 5.33% 2.42% -5.89% -9.22% -18.45% -13.05% -10.99% PAT Growth -118.25% - - - 118.96% - - - - - EPS -0.70 -0.97 -0.74 -3.52 6.53 2.98 -6.72 -9.96 -20.16 -20.77 -20.13

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 1,143.67 1,038.73 891.34 779.64 756.60 762.52 697.42 653.25 660.45 965.08 1,136.09 Net Sales Growth 21.89% 16.54% 14.33% 3.05% -0.78% 9.33% 6.76% -1.09% -31.57% -15.05% Cost Of Goods Sold 607.76 526.58 451.44 396.66 403.36 390.56 392.19 353.01 407.39 754.92 911.94 Gross Profit 535.91 512.15 439.90 382.98 353.24 371.96 305.24 300.23 253.07 210.16 224.15 GP Margin 46.86% 49.31% 49.35% 49.12% 46.69% 48.78% 43.77% 45.96% 38.32% 21.78% 19.73% Total Expenditure 942.82 843.11 708.54 636.16 630.48 628.43 591.47 545.97 571.69 906.18 1,064.59 Power & Fuel Cost - 57.54 37.31 34.65 37.44 29.58 26.00 22.65 34.78 36.82 31.61 % Of Sales - 5.54% 4.19% 4.44% 4.95% 3.88% 3.73% 3.47% 5.27% 3.82% 2.78% Employee Cost - 104.66 97.86 95.92 90.98 88.12 69.65 62.76 50.65 44.95 40.57 % Of Sales - 10.08% 10.98% 12.30% 12.02% 11.56% 9.99% 9.61% 7.67% 4.66% 3.57% Manufacturing Exp. - 63.58 64.24 59.30 50.06 63.50 43.40 38.56 30.13 26.35 29.14 % Of Sales - 6.12% 7.21% 7.61% 6.62% 8.33% 6.22% 5.90% 4.56% 2.73% 2.56% General & Admin Exp. - 36.22 27.17 27.58 27.27 28.69 23.33 21.54 20.33 22.37 21.05 % Of Sales - 3.49% 3.05% 3.54% 3.60% 3.76% 3.35% 3.30% 3.08% 2.32% 1.85% Selling & Distn. Exp. - 38.86 28.74 21.65 21.30 27.92 29.06 28.87 28.33 13.95 24.12 % Of Sales - 3.74% 3.22% 2.78% 2.82% 3.66% 4.17% 4.42% 4.29% 1.45% 2.12% Miscellaneous Exp. - 15.67 1.77 0.40 0.07 0.06 7.86 18.57 0.09 6.82 24.12 % Of Sales - 1.51% 0.20% 0.05% 0.01% 0.01% 1.13% 2.84% 0.01% 0.71% 0.54% EBITDA 200.83 195.62 182.80 143.48 126.12 134.09 105.95 107.28 88.76 58.90 71.50 EBITDA Margin 17.56% 18.83% 20.51% 18.40% 16.67% 17.59% 15.19% 16.42% 13.44% 6.10% 6.29% Other Income 44.55 43.48 22.71 33.46 36.91 25.82 22.62 15.91 22.25 14.17 17.87 Interest 95.18 95.53 100.22 106.65 92.24 35.38 90.27 106.42 117.29 116.66 139.72 Depreciation 135.76 131.04 87.29 90.06 104.05 86.62 88.26 84.75 84.29 65.77 54.35 PBT 14.46 12.53 18.01 -19.77 -33.26 37.92 -49.96 -67.98 -90.56 -109.35 -104.71 Tax 14.62 14.68 21.16 1.42 20.73 14.01 -16.17 -24.09 -23.98 -20.05 -0.94 Tax Rate 101.11% 117.16% 117.49% -7.18% 41.73% 38.94% 29.24% 29.10% 16.73% 14.11% 0.79% PAT -0.16 -2.15 -3.15 -21.19 28.95 21.98 -39.13 -58.69 -119.37 -122.01 -117.90 PAT before Minority Interest -0.16 -2.15 -3.15 -21.19 28.95 21.98 -39.13 -58.69 -119.37 -122.01 -117.90 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -0.01% -0.21% -0.35% -2.72% 3.83% 2.88% -5.61% -8.98% -18.07% -12.64% -10.38% PAT Growth -100.62% - - - 31.71% - - - - - EPS -0.03 -0.36 -0.53 -3.59 4.90 3.72 -6.62 -9.93 -20.20 -20.64 -19.95

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 632.56 638.69 644.61 590.29 543.37 525.88 514.69 592.35 722.86 851.81 Share Capital 59.81 59.81 59.81 48.29 46.00 45.46 41.68 41.68 40.96 39.27 Total Reserves 572.75 578.89 584.80 542.00 495.82 477.95 473.01 550.67 672.57 803.21 Non-Current Liabilities 806.37 832.95 828.33 901.32 437.80 494.76 717.24 811.33 983.36 857.58 Secured Loans 839.07 875.41 885.96 953.86 503.97 563.69 666.84 723.03 862.23 756.52 Unsecured Loans 0.00 0.00 4.93 11.72 16.52 28.32 79.48 93.11 102.17 61.64 Long Term Provisions 17.03 15.73 14.76 14.34 13.32 9.16 0.00 0.00 0.00 0.00 Current Liabilities 313.61 286.71 309.29 342.34 919.84 994.23 949.20 829.78 623.76 654.80 Trade Payables 163.32 123.96 127.12 115.70 116.58 94.95 129.45 129.74 206.34 193.29 Other Current Liabilities 81.47 89.49 99.23 134.13 491.94 493.59 316.09 249.99 23.04 26.89 Short Term Borrowings 63.86 72.58 82.94 92.52 311.31 405.70 503.66 450.05 390.97 421.97 Short Term Provisions 4.96 0.69 0.00 0.00 0.00 0.00 0.00 0.00 3.41 12.66 Total Liabilities 1,752.54 1,758.35 1,782.23 1,833.95 1,901.01 2,014.87 2,181.13 2,233.46 2,329.98 2,364.19 Net Block 626.79 737.64 842.93 900.99 924.38 1,032.35 1,098.52 1,116.60 1,172.53 1,169.39 Gross Block 1,315.21 1,298.09 1,355.90 1,378.74 1,349.06 1,406.63 1,420.29 1,404.00 1,404.04 1,350.08 Accumulated Depreciation 688.42 560.45 512.97 477.75 424.68 374.28 321.78 287.40 231.51 180.68 Non Current Assets 753.32 892.55 937.66 1,016.66 1,095.57 1,210.47 1,272.28 1,327.74 1,358.58 1,359.63 Capital Work in Progress 10.31 18.84 11.45 19.87 68.60 70.26 78.47 112.83 78.10 161.30 Non Current Investment 110.68 55.33 26.36 38.88 39.12 39.35 26.38 26.33 27.21 27.17 Long Term Loans & Adv. 2.84 65.97 56.92 56.92 63.48 54.21 68.92 71.97 80.74 1.76 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 14.31 0.00 0.00 0.00 0.00 Current Assets 999.21 865.80 844.56 817.29 805.44 804.41 908.85 905.72 971.39 1,004.57 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 Inventories 414.00 354.41 342.82 316.61 316.91 343.56 356.02 348.31 377.03 451.44 Sundry Debtors 428.35 400.15 384.66 333.47 382.82 340.82 358.82 374.90 427.27 393.87 Cash & Bank 9.38 9.95 8.84 29.09 6.43 14.21 21.43 18.48 18.92 17.75 Other Current Assets 147.48 58.63 38.73 41.82 99.27 105.81 172.58 164.03 148.17 141.40 Short Term Loans & Adv. 92.22 42.66 69.51 96.30 86.22 89.49 159.33 145.42 127.09 114.21 Net Current Assets 685.60 579.09 535.27 474.95 -114.40 -189.83 -40.35 75.94 347.63 349.77 Total Assets 1,752.53 1,758.35 1,782.22 1,833.95 1,901.01 2,014.88 2,181.13 2,233.46 2,329.97 2,364.20

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 600.97 603.51 640.64 587.81 553.24 531.32 517.43 594.85 725.23 853.44 Share Capital 59.81 59.81 59.81 48.29 46.00 45.46 41.68 41.68 40.96 39.27 Total Reserves 541.17 543.70 580.83 539.53 505.69 483.39 475.74 553.17 674.95 804.85 Non-Current Liabilities 813.57 840.15 828.33 901.32 437.80 494.76 717.24 811.33 983.36 859.34 Secured Loans 847.78 884.13 885.96 953.86 503.97 563.69 666.84 723.03 862.23 756.52 Unsecured Loans 0.00 0.00 4.93 11.72 16.52 28.32 79.48 93.11 102.17 63.40 Long Term Provisions 17.03 15.73 14.76 14.34 13.32 9.16 0.00 0.00 0.00 0.00 Current Liabilities 334.50 314.52 323.07 356.00 935.93 1,005.02 950.81 832.82 630.01 663.04 Trade Payables 175.95 138.82 135.23 126.68 128.64 102.36 132.43 134.11 213.71 203.42 Other Current Liabilities 79.13 81.29 72.92 136.49 490.25 496.93 314.60 248.67 21.50 24.98 Short Term Borrowings 74.03 93.43 114.93 92.52 311.31 405.70 503.66 450.05 390.97 421.97 Short Term Provisions 5.39 0.98 0.00 0.31 5.73 0.03 0.12 0.00 3.83 12.67 Total Liabilities 1,748.93 1,758.09 1,792.04 1,845.13 1,926.97 2,031.10 2,185.48 2,239.00 2,338.60 2,375.82 Net Block 627.56 738.65 843.14 901.20 924.59 1,032.56 1,098.73 1,116.82 1,173.77 1,170.63 Gross Block 1,318.99 1,302.04 1,359.32 1,378.95 1,349.27 1,406.84 1,420.51 1,404.21 1,405.28 1,351.32 Accumulated Depreciation 691.42 563.38 516.18 477.75 424.68 374.28 321.78 287.40 231.51 180.68 Non Current Assets 672.55 813.91 929.00 1,009.05 1,087.71 1,202.46 1,263.78 1,319.18 1,349.72 1,350.77 Capital Work in Progress 10.31 18.84 11.45 19.87 68.60 70.26 78.47 112.83 78.10 161.30 Non Current Investment 29.06 35.53 17.45 31.03 31.02 31.09 17.63 17.52 17.07 17.04 Long Term Loans & Adv. 2.91 6.11 56.95 56.95 63.50 54.24 68.96 72.00 80.78 1.80 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 14.31 0.00 0.00 0.00 0.00 Current Assets 1,074.37 941.88 863.03 836.09 839.26 828.64 921.70 919.82 988.89 1,025.06 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 Inventories 428.50 375.67 342.82 316.61 316.91 343.56 356.02 348.31 377.03 451.44 Sundry Debtors 454.78 432.39 396.45 350.85 407.76 357.27 372.45 389.04 443.85 412.71 Cash & Bank 21.48 11.60 10.58 29.97 9.45 16.13 22.58 19.84 20.59 18.28 Other Current Assets 169.61 56.33 38.73 41.82 105.14 111.69 170.66 162.64 147.41 142.52 Short Term Loans & Adv. 113.45 65.90 74.45 96.84 92.09 95.37 157.41 144.03 126.33 115.33 Net Current Assets 739.87 627.36 539.96 480.08 -96.67 -176.37 -29.11 87.01 358.87 362.01 Total Assets 1,746.92 1,755.79 1,792.03 1,845.14 1,926.97 2,031.10 2,185.48 2,239.00 2,338.61 2,375.83

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 136.26 135.03 123.16 -74.63 71.46 92.67 80.44 99.92 66.32 -46.12 PBT 9.69 16.12 -19.56 -24.01 30.52 -50.85 -68.55 -90.49 -110.49 -105.77 Adjustment 225.59 179.35 176.02 176.17 103.64 167.95 186.52 169.91 144.59 112.39 Changes in Working Capital -99.02 -60.43 -33.30 -226.79 -62.70 -24.43 -37.53 23.91 41.47 -52.74 Cash after chg. in Working capital 136.26 135.03 123.16 -74.63 71.46 92.67 80.44 103.33 75.57 -46.12 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -3.41 -9.25 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 2.76 -10.17 -10.15 -2.34 -17.25 -30.99 -29.56 -36.64 -27.39 -48.21 Net Fixed Assets -8.59 50.42 31.26 19.05 59.23 21.87 18.07 -34.69 29.24 -176.19 Net Investments -55.35 -28.97 12.52 0.24 0.23 -12.97 -0.05 0.88 0.06 2.06 Others 66.70 -31.62 -53.93 -21.63 -76.71 -39.89 -47.58 -2.83 -56.69 125.92 Cash from Financing Activity -139.59 -123.75 -133.26 99.62 -61.98 -68.90 -47.92 -63.72 -37.76 65.84 Net Cash Inflow / Outflow -0.57 1.11 -20.25 22.66 -7.78 -7.22 2.95 -0.44 1.17 -28.48 Opening Cash & Equivalents 9.95 8.84 29.09 6.43 14.21 21.43 18.48 18.92 17.75 46.23 Closing Cash & Equivalent 9.38 9.95 8.84 29.09 6.43 14.21 21.43 18.48 18.92 17.75

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 150.27 134.95 125.24 -64.40 73.09 95.57 79.43 98.40 65.53 -46.60 PBT 12.53 18.01 -19.77 -33.26 37.87 -49.96 -67.98 -90.57 -109.35 -104.78 Adjustment 225.66 179.35 176.02 186.26 103.64 167.95 186.30 169.93 144.59 111.52 Changes in Working Capital -87.92 -62.41 -31.01 -214.80 -68.41 -22.42 -38.89 22.87 39.54 -53.34 Cash after chg. in Working capital 150.27 134.95 125.24 -61.80 73.09 95.57 79.43 102.23 74.78 -46.60 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 -2.60 0.00 0.00 0.00 -3.83 -9.25 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 4.77 -10.17 -9.10 -12.47 -17.40 -30.94 -29.56 -35.61 -27.39 -48.36 Net Fixed Assets -8.59 50.42 31.26 19.05 59.23 21.87 18.07 -34.69 29.24 -176.19 Net Investments -55.35 -28.97 12.52 0.24 0.23 -12.97 -0.05 0.88 0.06 2.06 Others 68.71 -31.62 -52.88 -31.76 -76.86 -39.84 -47.58 -1.80 -56.69 125.77 Cash from Financing Activity -140.88 -123.75 -133.26 99.62 -61.98 -68.90 -47.92 -63.72 -37.76 66.31 Net Cash Inflow / Outflow 14.17 1.03 -17.12 22.76 -6.30 -4.27 1.94 -0.94 0.38 -28.65 Opening Cash & Equivalents 11.60 10.58 29.97 9.45 16.13 22.58 19.84 20.59 18.28 46.92 Closing Cash & Equivalent 25.77 11.61 10.58 29.97 9.45 16.13 21.78 19.84 20.59 17.82

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 73.68 72.30 70.88 73.53 63.40 56.86 56.11 66.60 92.49 125.37 ROA -0.33% -0.25% -1.15% 2.07% 0.90% -1.89% -2.67% -5.22% -5.23% -5.21% ROE -1.32% -1.04% -5.41% 12.12% 6.51% -16.41% -23.42% -36.57% -28.18% -21.81% ROCE 7.41% 8.24% 6.04% 10.65% 4.45% 2.14% 1.38% -1.52% -1.53% 1.17% Fixed Asset Turnover 0.76 0.65 0.55 0.53 0.53 0.49 0.47 0.47 0.70 0.92 Receivable days 151.57 165.89 173.48 179.63 179.41 184.06 203.30 219.71 156.29 112.06 Inventory Days 140.57 147.38 159.30 158.87 163.74 184.04 195.15 198.67 157.68 156.77 Payable days 107.58 107.82 65.88 60.20 57.51 63.08 84.37 96.76 79.37 74.64 Cash Conversion Cycle 184.56 205.45 266.90 278.30 285.64 305.03 314.08 321.62 234.60 194.19 Total Debt/Equity 2.14 2.28 2.38 3.18 3.76 4.87 6.32 5.17 3.58 2.52 Interest Cover 1.08 1.16 0.82 1.64 1.81 0.38 0.22 -0.22 -0.23 0.14

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 68.33 66.35 70.21 73.01 65.58 58.08 56.78 67.21 93.07 125.78 ROA -0.12% -0.18% -1.17% 1.53% 1.11% -1.86% -2.65% -5.22% -5.18% -5.13% ROE -0.54% -0.78% -5.56% 8.99% 7.89% -15.89% -23.11% -36.36% -27.88% -21.56% ROCE 7.85% 8.31% 5.97% 9.25% 4.59% 2.19% 1.40% -1.52% -1.46% 1.24% Fixed Asset Turnover 0.80 0.67 0.57 0.56 0.56 0.51 0.48 0.48 0.71 0.96 Receivable days 154.46 168.41 174.12 182.19 181.25 185.94 206.44 223.20 158.98 113.33 Inventory Days 140.01 145.99 153.65 152.15 156.48 178.26 190.95 194.38 153.77 149.59 Payable days 109.09 110.78 68.85 63.73 60.79 64.19 12.73 29.95 80.99 75.54 Cash Conversion Cycle 185.38 203.62 258.91 270.60 276.94 300.00 384.67 387.63 231.76 187.37 Total Debt/Equity 2.35 2.56 2.48 3.21 4.38 4.77 6.25 5.12 3.56 2.51 Interest Cover 1.13 1.18 0.81 1.54 2.02 0.39 0.22 -0.22 -0.22 0.15

Top Investors:

edelweiss india special situations fund-ii

ec special situations fund

ashokkumar chandak

edelweiss india special situations fund - eisaf ii onshore fund

sri ganesh biotech private limited

conquer investment & finance pvt. ltd

Annual Reports:

News Update:

Ind-Swift Laboratories wins ‘Asia's best Company for the year 2022’ award
27th Dec 2022, 14:58 PM

The company has been awarded by Berkshire Media LLC, USA
Read More
Ind-Swift Lab. - Quarterly Results
8th Nov 2022, 18:17 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback